Literature DB >> 3044426

Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.

R V Lewis1, D G McDevitt.   

Abstract

It has been suggested that patients in whom atrial fibrillation (AF) is associated with poor exercise tolerance respond better to treatment with xamoterol plus digoxin than to digoxin alone; this may be attributable to better control of exercise induced tachycardia. We have examined data obtained during studies comparing digoxin and two calcium antagonists in the treatment of AF to see whether subgroups of patients with particularly poor exercise tolerance, rheumatic heart disease or rapid post-exercise heart rates might derive particular benefit from one modality of treatment as opposed to another. The results do not indicate that calcium antagonists improve exercise tolerance compared with digoxin in any of these subgroups despite achieving consistently better control of exercise induced tachycardia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044426      PMCID: PMC1386435          DOI: 10.1111/j.1365-2125.1988.tb03352.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  A comparison of verapamil and digoxin in the treatment of atrial fibrillation.

Authors:  R Lewis; M Lakhani; T A Moreland; D G McDevitt
Journal:  Eur Heart J       Date:  1987-02       Impact factor: 29.983

2.  Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.

Authors:  A O Molajo; M O Coupe; D H Bennett
Journal:  Br Heart J       Date:  1984-10

3.  Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.

Authors:  R Lang; H O Klein; E Weiss; D David; P Sareli; A Levy; J Guerrero; E Di Segni; E Kaplinsky
Journal:  Chest       Date:  1983-03       Impact factor: 9.410

  3 in total
  2 in total

1.  Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.

Authors:  E L Ang; W L Chan; J G Cleland; D Moore; S J Krikler; N D Alexander; C M Oakley
Journal:  Br Heart J       Date:  1990-10

2.  Clinical pharmacology of chronic atrial fibrillation.

Authors:  R Lewis; J McClay
Journal:  J R Coll Physicians Lond       Date:  1988-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.